Paclitaxel in breast cancer – drug resistance and strategies to counteract it

Paclitaxel in breast cancer – drug resistance and strategies to counteract it

Despite significant progress in the last few decades in breast cancer biology and the use of different therapeutic strategies, this cancer remains a serious clinical problem. Paclitaxel (PTX) is used to treat breast cancer both as a monotherapy and in combination with other anticancer drugs dependin...

Full description

Bibliographic Details
Main Authors: Alicja Zajdel, Daniel Wolny, Magdalena Kałucka-Janik, Adam Wilczok
Format: Article
Language:English
Published: Index Copernicus International S.A. 2019-10-01
Series:Postępy Higieny i Medycyny Doświadczalnej
Subjects:
breast cancer
paclitaxel
drug resistance
Online Access:http://phmd.pl/gicid/01.3001.0013.5251

Similar Items

Similar Items